OraSure Technologies | OSUR - Le Bénéfice D'Exploitation

Prix De L'Action
2.95
Variation Quotidienne
-0.07 -2.16%
Mensuellement
8.67%
Annuel
-11.03%
Q1 Prévisions
3.05




Le Bénéfice D'Exploitation Changement Date
Agilent USD 353M 90M 2025-12
AngioDynamics USD -9.97M 1.12M 2025-02
Becton, Dickinson and Co. USD 663M 163M 2025-12
Bio Techne USD 54.46M 6.8M 2025-12
Bio-Rad Laboratories USD 63.9M 13.2M 2025-09
Bruker USD 76.3M 7.6M 2025-12
Cerus USD -1.45M 488K 2024-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Danaher USD 1.5B 348M 2025-12
Dentsply International USD 538M 26M 2025-12
Dexcom USD 323M 80.5M 2025-12
Exact Sciences USD -25M 22.85M 2025-09
Hologic USD 237M 16M 2025-12
Illumina USD 256M 6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 865.3M 97.5M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Mesa Laboratories USD 5.78M 2.27M 2024-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Myriad Genetics USD -23.3M 10.8M 2025-09
OraSure Technologies USD -6M 3.26M 2024-09
Quidel USD -37.3M 667.5M 2025-12
Repligen USD 19.97M 7.29M 2025-12
Revvity USD 145.83M 47.49M 2025-12
STAAR Surgical USD -10.93M 29.42M 2025-12
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Trinity Biotech USD -509K 6.27M 2025-09
Waters USD 270.52M 78.4M 2025-12